Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

ABPI warns of skills shortage in UK caused by lack of STEM grads and Brexit

January 30, 2019 Research and Development ABPI, UK, eomployment, skills, stem, work

The UK is falling behind Europe and the rest of the world in regards to the number of students studying …
News
shutterstock_168864905

Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance

January 29, 2019 Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma

UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …
News
alexander_hardy

Alexander Hardy returns to Genentech as new CEO

January 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
News

Philip Hampton to step down from chairman role at GSK

January 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
Appointment
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Celgene, NHS, health, pharma, venlytxo

While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …
News
antibiotic_sensitvity_and_resistance

UK government launches plan to control AMR by 2040

January 24, 2019 Medical Communications, Research and Development AMR, Antibiotics, Davos, Matt Hancock, UK

The British government has announced a plan through which it will incentivise pharmaceutical companies to develop drugs aimed at tackling …
News

Cost of insulin doubled between 2012 and 2016

January 23, 2019 Research and Development USA, healthcare, insulin, insurance, pricing

The cost of insulin almost doubled in the United States between 2012 and 2016, according to a report by the …
News
gsk_rd_harlow

GSK acquires oncology firm Tesaro for $5.1 billion

January 23, 2019 Research and Development Cancer, GSK, Tesaro, oncology, ovarian cancer

British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …
News

NICE recommend digital CBT for young people with mild depression

January 23, 2019 Research and Development CBT, Digital CBT, NHS, psychology, psychotherapy

Britain’s cost effectiveness body NICE has recommended digital Cognitive Behavioural Therapy (CBT) for children with mild depression as a first …
News
amgen_hq

Amgen’s Blincyto secures expanded indication in Europe for acute lymphoblastic leukaemia

January 23, 2019 Research and Development, Sales and Marketing Ammgen, Cancer, Europe, European Commission, blincyto, leukaemia, pharma

The European Commission has chosen to expand the authorised indication for Amgen’s Blincyto (blinatumomab) in the region, it has emerged, …
News

Including prices on TV ads only works when the price is listed alone

January 23, 2019 Research and Development Trump, USA, pharma, pricing

Requiring pharmaceutical companies to publish the price of their drugs on adverts on TV, would probably not help to control …
News
mesothelioma

Pushing for progress in mesothelioma

January 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, mesothelioma, pharma

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …
Feature
lilly_building_with_american_flag_web

Lilly’s Lartruvo/chemo combo surprises with Phase 3 failure in soft tissue carcinoma

January 21, 2019 Research and Development, Sales and Marketing Cancer, Eli Lilly, carcinoma, chemotherapy, pharma, trial failure

Eli Lilly has reluctantly pulled back the curtain on new Phase 3 data for its platelet-derived growth factor receptor alpha …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Netherlands, Novo Nordisk, Roche, astra zeneca, prcing, sequiris, top 10, uk politics

Job switches were the theme of this week as AstraZeneca lost three, high levels executives to biotechs amid a restructuring …
News
zeiss_microscopy

Scientists prevent axon self-destruct mechanism using gene therapy

January 17, 2019 Research and Development Axon, gene therapy, health, neuropathy

Scientists at the University of Washington have developed a gene therapy that prevents the process through which axons (nerve fibres) …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026